- Country: Ukraine
- Summary: Dexketoprofen Solution for Injection 25 Mg/Ml in 2 Ml; Ropivacaine, Solution for Injection, 7.5 Mg/Ml, 10 Ml Each; Citicoline Solution for Infusions 10 Mg/Ml in 100 Ml; Ipidacrine Hydrochloride 20 Mg Tablets;...
- UAT Ref No: 130264443
- Deadline: 19 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 295703.11
- Notice Type: Tender
- Document Ref. No.: UA-2025-11-14-009584-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Dexketoprofen solution for injection 25 mg/ml in 2 ml; Ropivacaine, solution for injection, 7.5 mg/ml, 10 ml each; Citicoline solution for infusions 10 mg/ml in 100 ml; Ipidacrine hydrochloride tablets of 20 mg; Methotrexate, solution for injection, 50 mg/ml, 0.15 ml each; Methotrexate, solution for injection, 50 mg/ml, 0.2 ml each; Methotrexate, solution for injection, 50 mg/ml, 0.3 ml each; Tigecycline powder for solution for infusion 50 mg bottle; Dexketoprofen granules for oral solution 25 mg each; Diphenhydramine, solution for injection, 10 mg/ml, 1 ml each Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Citicoline solution for infusions 10 mg/ml 100 ml Classification according to ATX: N06BX06, Classification according to INN: Citicoline, Release form: Solution for infusions, Dose of the active substance: 10 mg/ml, Volume: 100 milliliters, Type of packaging: Vial, Vial polymer; Classification according to ATC: N07AA, Classification according to INN: Ipidacrine, Release form: Tablets, Dose of active substance: 20 mg, Packaging type: Blister; Classification according to INN: Tigecycline, Classification according to ATC: J01AA12, Release form: Powder for solution for infusion, Dose of active substance: 50 mg, Type of packaging: Vial Name Classifier and its corresponding code Quantity/Units of measurement Place delivery Date of delivery Name DK 021:2015: 33600000-6 — Pharmaceutical products Citicoline solution for infusions 10 mg/ml per 100 ml Classification according to ATX: N06BX06, Classification according to INN: Citicoline, Release form: Solution for infusions, Dose of active substance: 10 mg/ml, Volume: 100 milliliters, Type of packaging: Vial, Vial polymer; Classification according to ATC: N07AA, Classification according to INN: Ipidacrine, Release form: Tablets, Dose of active substance: 20 mg, Packaging type: Blister; Classification according to INN: Tigecycline, Classification according to ATC:...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDexketoprofen Solution for Injection 25 Mg/Ml in 2 Ml; Ropivacaine, Solution for Injection, 7.5 Mg/Ml, 10 Ml Each; Citicoline Solution for Infusions 10 Mg/Ml in 100 Ml; Ipidacrine Hydrochloride 20 Mg Tablets;... - Ukraine Tender
The MUNICIPAL NON-COMMERCIAL ENTERPRISE "ODESA REGIONAL CHILDREN'S CLINICAL HOSPITAL" OF ODESSA REGIONAL COUNCIL, a Government sector organization in Ukraine, has announced a new tender for Dexketoprofen Solution for Injection 25 Mg/Ml in 2 Ml; Ropivacaine, Solution for Injection, 7.5 Mg/Ml, 10 Ml Each; Citicoline Solution for Infusions 10 Mg/Ml in 100 Ml; Ipidacrine Hydrochloride 20 Mg Tablets;.... This tender is published on UkraineTenders under UAT Ref No: 130264443 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-19.
The estimated tender value is UAH 295703.11, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
